Cite
MLA Citation
TS Plantinga et al.. “Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease.” Clinical pharmacology & therapeutics, vol. 102, no. 6, 2017, pp. 1017–1024. http://access.bl.uk/ark:/81055/vdc_100053871039.0x00005e